Randy Jones joins Windy Hill Medical as Vice President, Preclinical Development

Life Science Partner recruits former Vice President of Biology Services of Ricerca Biosciences

Life Science Partner announces the recruitment of Randy Jones, PhD, an experienced pharmaceutical development executive, to Windy Hill Medical to become Vice President, Preclinical Development.  Windy Hill Medical is a California-based medical device and pharmaceutical company focused on the development of products to reduce the risk of developing breast cancer in patients deemed to be at high risk.

In Jones’ previous role at Ricerca, a preclinical chemistry and biology services company, he was responsible for the operational and profit and loss responsibility for all areas of the Biology Division as well as new business development and the integration of IND/NDA programs in biology and chemistry.  Previously, Jones served as the Director of Toxicology at the Arkansas Division of Charles River Laboratories.

“Jones is an experienced and effective general manager, unflappable in style, with a broad understanding of the pharmaceutical industry and how to build successful teams,” noted Tom Callaway, MD, founder and president of Life Science Partner.  “With his experience in medical devices as well as biopharmaceutical services, he will serve Windy Hill well in its mission to bring lasting improvements for high risk patients.”

In his role as Vice President of  Preclinical Development, Jones will have responsibility for overseeing the continued pharmaceutical development of Windy Hill Medical’s expanding portfolio of compounds under development for the localized therapy of breast cancer.  He will provide commercialization strategy and regulatory oversight to the Windy Hill team.

Jones earned his D.V.M at Iowa State University and his PhD in Pharmacology and Toxicology from the University of Georgia in Athens.